Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Launches Sales and Service Operation in India with Labindia

NEW YORK, April 26 (GenomeWeb News) - PerkinElmer and Labindia Instruments have jointly launched PerkinElmer India, a direct sales, service, and marketing operation targeting India's life science and analytical instrumentation markets, the companies said today.


PerkinElmer holds a majority stake in the joint venture, which will be headquartered in Thane, India and will employ about 180 people.


"India represents a key growth market for a number of PerkinElmer businesses, including biopharma, environmental and chemical, and genetic screening," Peter Coggins, president of PerkinElmer's life and analytical sciences unit, said in a statement. "We are pleased to be working with Labindia to bring ... our ... product and service portfolio to India's rapidly expanding community of scientists and researchers."


The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.